Cargando…
Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
Ejemplares similares
-
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
por: Lewis, Nathaniel M, et al.
Publicado: (2022) -
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States
por: Turbyfill, Caitlin, et al.
Publicado: (2022) -
Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness
por: Stephenson, Meagan, et al.
Publicado: (2022) -
Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)—United States, March–June and October–December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes
por: Sami, Samira, et al.
Publicado: (2021) -
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
por: Lauring, Adam S, et al.
Publicado: (2022)